Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2014-05-07 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2014-05-07 English
10-Q
Interim / Quarterly Report Q1 2014
2014-05-02 English
Regulatory Filings 2014
Regulatory Filings
2014-05-02 English
PRIMARY DOCUMENT
Director's Dealing
2014-04-28 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filing dated April 24, 2014, reporting the results of the annual shareholders meeting including election of directors, advisory vote on executive compensation, ratification of the independent auditor, and shareholder proposal voting results. It also includes a declaration of a quarterly dividend. The key section is 'Item 5.07 Submission of Matters to a Vote of Security Holders' which details the voting results. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is about the official voting results from the annual meeting, not the meeting materials or the annual report itself. The length is about 4975 characters, sufficient to contain detailed voting results. Therefore, the correct classification is DVA with high confidence.
2014-04-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 15, 2014, reporting the results of operations and financial condition for the first quarter ended March 30, 2014. It includes a press release announcing sales and earnings and unaudited supplementary sales data and condensed consolidated statement of earnings for the quarter. The 8-K form is used for current reports to announce major events, including earnings releases. The document is relatively short (2396 characters) and primarily serves as an announcement of quarterly financial results rather than a full interim or quarterly report with comprehensive financial statements and analysis. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2014-04-15 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.